Public Health - Recommendations for Immunizations, Screenings, and Preventive Services - Pharmacist Administration and Required Health Insurance Coverage (The Vax Act)
HB0637, the Vax Act, restructures how Maryland identifies recommended immunizations, screenings, and other preventive services. It directs the Secretary of Health to issue recommendations for vaccines and preventive services for infants, children, and adults based on generally accepted scientific consensus and clinical guidance, including guidance from major medical organizations and federal public health bodies. For non-immunization preventive services that have not already been recommended by HHS or rated A or B by the U.S. Preventive Services Task Force, the Secretary must first hold at least a 30-day notice-and-comment period, obtain an analysis from the Maryland Health Care Commission, and explain the basis for the recommendation. The Department must publish and distribute the recommendations to health professionals and the Maryland Insurance Administration.
The bill also expands and updates pharmacist vaccination authority. Pharmacists may administer certain vaccines to individuals age 7 and older if the vaccine is recommended by the Secretary under the new Health-General provision, in addition to vaccines recommended by ACIP or approved/authorized by FDA. The bill retains training, CPR certification, recordkeeping, and referral requirements, and preserves the existing authority for pharmacists to administer influenza, COVID-19, and public-health-emergency vaccines to individuals age 3 and older under specified conditions.
HB0637 further changes Maryland insurance coverage mandates for preventive care. It ties required coverage for immunizations, screenings, and preventive services to the Secretary’s recommendations under the new law, and requires carriers to provide that coverage without cost-sharing beginning for plan years starting on or after a date that is three months after the recommendations are issued, but no earlier than the statute’s effective framework. It also updates child wellness coverage requirements so childhood and adolescent immunizations and other pediatric preventive services reflect Secretary-issued updates, while preserving existing coverage for newborn screening, hearing screening, developmental screening, obesity evaluation, and related services. The bill repeals obsolete pertussis-specific provisions.
The general sentiment reflected by the bill’s enactment is supportive of expanding and modernizing preventive health access, particularly vaccination access and insurance coverage for recommended services. Because the bill was enacted without recorded committee transcripts or roll-call votes in the provided materials, there is no documented floor debate or formal vote pattern to indicate broader opposition or support. The structure of the bill suggests an emphasis on aligning Maryland policy with evidence-based medical guidance while adding procedural safeguards for new preventive-service recommendations.
The main points of potential contention are the scope of the Secretary of Health’s authority and the extent to which state recommendations can drive insurance coverage and pharmacist practice. The notice-and-comment requirement and Maryland Health Care Commission analysis for certain preventive services appear designed to address concerns about transparency, scientific basis, and administrative discretion. Another possible issue is the expansion of pharmacist-administered vaccines to those recommended by the Secretary, which could raise questions among providers or insurers about oversight, scope of practice, and how quickly coverage and practice standards should change.
HB0637 adds a new Health-General section requiring the Secretary of Health to issue evidence-based recommendations for immunizations, screenings, and preventive services, and it amends insurance and pharmacy statutes to conform coverage and pharmacist administration rules to those recommendations. It repeals obsolete pertussis language, expands the list of vaccines pharmacists may administer to include vaccines recommended by the Secretary, and requires insurers to cover specified preventive services without cost-sharing according to the updated recommendation framework. The bill affects the Health – General, Health Occupations, and Insurance articles and applies to policies and plans issued, delivered, or renewed on or after January 1, 2027.
The bill appears to have been viewed favorably as a public-health and preventive-care measure, with its enactment indicating legislative and executive approval of the policy direction. The available record does not include committee testimony or vote tallies, so there is no direct evidence of organized support or opposition in the provided materials. Overall, the measure reflects a pro-vaccination, pro-prevention approach that seeks to align state law with scientific and clinical guidance.
The likely areas of contention are the Secretary of Health’s expanded role in setting recommendations, the procedural standards for adopting new preventive-service recommendations, and the downstream effect on insurance mandates and pharmacist authority. Supporters would likely emphasize evidence-based updates, broader access, and reduced cost barriers, while critics may focus on administrative discretion, the pace of adopting new services, and whether state-level recommendations should automatically trigger coverage and practice changes. The bill’s added notice-and-comment and Maryland Health Care Commission review requirements suggest lawmakers anticipated concerns about transparency and accountability.